Detection and Management of Sinusitis in a Single-center Prospective Cohort of Patients With Exudative AMD (SINE)
NCT05547633 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-12-10
Summary
An inflammatory component associated with AMD has been highlighted by genetic associations of predisposition to AMD, as well as by the recently demonstrated link between AMD and periodontitis.
Some patients followed at the Fondation Adolphe de Rothschild Hospital for wet AMD seemed to show an improvement of neovascular activity (less need for intravitreal injections of anti-VEGF) after treatment of their sinusitis.
The investigators would therefore like to assess the link between AMD and sinusitis, an infection close to the site of AMD.
Conditions
Interventions
- OTHER
-
sinusitis screening consultation
Questioning to look for suspicious anamnestic elements such as rhinorrhea, nasal obstruction, smell disorders, facial pain and clinical examination including nasofibroscopy. Patients with signs of sinusitis will be managed according to current recommendations (diagnostic imaging tests, medical treatment or even surgery if necessary).
Sponsors & Collaborators
-
Fondation Ophtalmologique Adolphe de Rothschild
lead NETWORK
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-20
- Primary Completion
- 2027-01-31
- Completion
- 2028-04-30
Countries
- France
Study Locations
More Related Trials
-
Cohort Study of the Clinical Course of Macular Diseases in Japanese
NCT02081339 ·Status: UNKNOWN
-
Non-exudative Age-related Macular Degeneration
NCT01712841 ·Status: COMPLETED
-
A Study of EXG102-031 in Patients With wAMD (Everest)
NCT05903794 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration
NCT00767949 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).
NCT01624636 ·Status: TERMINATED ·Phase: PHASE2
-
Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD
NCT02357342 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration
NCT00712491 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study
NCT07164378 ·Status: RECRUITING ·Phase: NA
-
A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration
NCT01089517 ·Status: COMPLETED ·Phase: PHASE2
-
Plaqenil Role in Prevention of Age Related Macular Degeneration
NCT01541449 ·Status: UNKNOWN
-
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
NCT05438732 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
NCT03869684 ·Status: TERMINATED ·Phase: PHASE2
-
Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
NCT05769153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis
NCT05348148 ·Status: RECRUITING ·Phase: NA
-
A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration
NCT00569140 ·Status: COMPLETED ·Phase: PHASE1
-
Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)
NCT00935883 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies
NCT00698659 ·Status: TERMINATED
-
A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD
NCT05972473 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
NCT01024998 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
NCT01339949 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation and Treatment of Patients With Retinal Disease
NCT00005784 ·Status: COMPLETED
-
Evaluation of Neuroprotective Effect of Minocycline
NCT01297816 ·Status: UNKNOWN ·Phase: PHASE2
-
Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)
NCT03197493 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
NCT01414153 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
NCT01397409 ·Status: COMPLETED ·Phase: PHASE2